Shalnova, S. A. (2022). Comments on the section “Cardiovascular risk estimation” in the 2021 European Society of Cardiology guidelines on cardiovascular disease prevention in clinical practice. «SILICEA-POLIGRAF» LLC.
Chicago Style (17th ed.) CitationShalnova, S. A. Comments on the Section “Cardiovascular Risk Estimation” in the 2021 European Society of Cardiology Guidelines on Cardiovascular Disease Prevention in Clinical Practice. «SILICEA-POLIGRAF» LLC, 2022.
MLA (9th ed.) CitationShalnova, S. A. Comments on the Section “Cardiovascular Risk Estimation” in the 2021 European Society of Cardiology Guidelines on Cardiovascular Disease Prevention in Clinical Practice. «SILICEA-POLIGRAF» LLC, 2022.
Warning: These citations may not always be 100% accurate.